| Name | 2-(4-methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole |
|---|---|
| Synonyms |
Pifithrin-Beta
UNII-45I8QO7K37 Pifithrin-β |
| Description | Pifithrin-β is a potent p53 inhibitor with an IC50 of 23 μM. |
|---|---|
| Related Catalog | |
| Target |
IC50: 23 μM (p53)[1] |
| In Vitro | Pifithrin-α, an inhibitor of the p53 protein, is regarded as a lead compound for cancer and neurodegenerative disease therapy. Pifithrin-α is very unstable in culture medium and rapidly converts to its condensation product pifithrin-β, the N-acetyl derivative[2]. After 24 h, the viability assay shows that the pretreatments with 1 and 10 μM pifithrin-β exerts neuroprotective effects[3]. |
| References |
| Molecular Formula | C16H16N2S |
|---|---|
| Molecular Weight | 268.37700 |
| Exact Mass | 268.10300 |
| PSA | 45.54000 |
| LogP | 4.25000 |
| Storage condition | 2-8℃ |